IBRX - ImmunityBio, Inc.
IEX Last Trade
2.495
0.010 0.401%
Share volume: 520,443
Last Updated: Mon 13 Jan 2025 08:30:05 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$2.48
0.01
0.40%
Summary score
28%
Profitability
25%
Dept financing
25%
Liquidity
55%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
22.39%
Return on assets
-24.17%
Return on sales
-247308.62%
Return on invested capital
-53.19%
Total debt ratio
186.6%
Debt ratio change over timeo
-0.72%
Current Ratio
2.17%
Quick Ratio
2.17%
Cash Position Ratio
1.91%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
25.96%
Return on assets
-20.58%
Return on sales
-123335.42%
Return on invested capital
-70.49%
Total debt ratio
261.83%
Debt ratio change over timeo
-4.96%
Current Ratio
2.77%
Quick Ratio
2.76%
Cash Position Ratio
2.35%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
19.38%
Return on assets
-23.76%
Return on sales
-237990%
Return on invested capital
-88.7%
Total debt ratio
272.71%
Debt ratio change over time
-2.78%
Current Ratio
3.64%
Quick Ratio
3.64%
Cash Position Ratio
3.17%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-82.95%
Return on assets
-106.04%
Return on sales
291969.01%
Return on invested capital
-77.74%
Total debt ratio
-71.81%
Debt ratio change over time
-0.72%
Current Ratio
-2.86%
Quick Ratio
-2.86%
Cash Position Ratio
-2.74%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IBRX | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 22.39% | 13.03% | 18.15% | 6.63% |
| Return on assets | -24.17% | 2.28% | 3.22% | 5.84% |
| Return on sales | -247308.62% | 27.95% | 31.46% | 43.41% |
| Return on invested capital | -53.19% | 2.07% | 5.53% | 34.89% |
| Profitability | 25% | 42% | 56% | 82% |
| Total debt ratio | 186.6% | 91.02% | 90.77% | 24.67% |
| Debt ratio change over time | -0.72% | 435.59% | 17.23% | -0.06% |
| Dept financing | 25% | 37% | 13% | 3% |
| Current Ratio | 2.77% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 2.76% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 2.35% | 0.31% | 0.49% | 2.77% |
| Liquididy | 41% | 12% | 27% | 75% |
| Short-term ratios | IBRX | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | 25.96% | 0% | 0% | 5.91% |
| Return on assets | -20.58% | 1.6% | 2.14% | 4.97% |
| Return on sales | -123335.42% | 24.8% | 18.91% | 42.59% |
| Return on invested capital | -70.49% | 0% | 0% | 23.7% |
| Profitability | 25% | 23% | 22% | 81% |
| Total debt ratio | 261.83% | 94.49% | 93.35% | 24.56% |
| Debt ratio change over time | -4.96% | 0% | 0% | -0.62% |
| Dept financing | 25% | 9% | 34% | 2% |
| Current Ratio | 2.77% | 0.82% | 1.41% | 3.64% |
| Quick Ratio | 2.76% | 0.71% | 0.99% | 3.42% |
| Cash Position Ratio | 2.35% | 0.31% | 0.49% | 2.77% |
| Liquididy | 60% | 14% | 21% | 75% |